Biomaterials / biopolymers take a crucial role in various pharmaceutical and medical applications. The need for innovative novel biopolymers in a highly regulated environment requires efficiency, good documentation and high reproducibility of your R&D as well as quality control and your experiments at the same time.
Chemspeed provides high throughput and high output solutions which accelerate, standardize, digitize your R&D and quality control without compromise in areas such as:
Highly innovative technologies allow mimicking virtually any workflow in a fully automated way. This saves precious time and increases output and quality of your lab dramatically, by using concepts designed for chemists by chemists.
Monoolein-based liquid crystal phases are established media that are researched for various biological applications, including drug delivery.
As Rolf Gueller steps down as CEO of Chemspeed Technologies AG, we pause to reflect on the incredible journey from our founding to becoming a leading provider of high throughput and high output research & development and quality control workflow solutions.
BASEL, Switzerland – [March 7, 2024]: Bruker Corporation (Nasdaq: BRKR) is pleased to announce the successful closing of its acquisition of Chemspeed Technologies AG, a leading Swiss provider of automated laboratory R&D and QC workflow solutions.